MANGALAMBSEMangalam Drugs & Organics LtdMediumNeutral
Announced Mon, 18 May · 17:32 IST

Disclosure of notice of postal ballot /E- Voting seeking shareholders approval pursuant to Regulation 30 of SEBI LODR, 2015 . for reappointment of Shri Praveen Saxena as an Independent ....

Management Changes View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.5%1-day move
₹30.40
prior close
₹30.37
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.3-0.9-1.2-0.7+2.5+0.3-3.5-4.6-4.6-5.3-7.6-0.7-10.2
Up moveDown movePending
AI summary

Mangalam Drugs & Organics Limited is seeking shareholder approval via postal ballot for reappointment of Shri Praveen Saxena as an Independent Director for a second term of 5 years (March 21, 2026 to March 20, 2031). Saxena, who is 70 years old and holds a Ph.D. in Physics, was first appointed as Independent Director in March 2021. The Nomination and Remuneration Committee and Board both approved his reappointment on February 6, 2026, based on his performance evaluation during the first term and his expertise in renewable energy policy. This requires a Special Resolution under Section 149(10) of the Companies Act, 2013. Remote e-voting runs from May 19 to June 17, 2026.

Likely market impact

This is a routine board governance matter. The reappointment maintains continuity in board composition and independence. No governance concerns have been flagged. The resolution is expected to pass given board and committee recommendations.